Answer
In 2020, Emmanuelle Charpentier was awarded the Nobel Prize in Chemistry jointly with Jennifer A. Doudna for the development of a method for genome editing. This revolutionary technique, known as CRISPR-Cas9, utilizes a protein-RNA complex to precisely target and edit DNA sequences, holding immense potential for treating genetic diseases, modifying crops, and advancing scientific research.